Monopar Therapeutics Cash Flow Statement (2016-2020) | MNPR

Cash Flow Statement Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020
Operating Activities
Net Income -0.37M-0.59M-14.90M-0.74M-0.90M-0.67M-0.67M-0.93M-1.41M-0.93M-0.76M-1.22M
Share-based Compensation 0.20M0.04M0.06M0.11M0.09M0.09M0.23M0.23M0.26M0.24M0.28M0.34M0.37M0.28M
Gains from Investment Securities -0.07M
Cash from Operations -0.31M-0.31M-1.19M-0.82M-0.81M-0.75M-0.60M-0.52M-1.00M-0.74M-0.61M-0.67M-1.13M-1.00M-1.30M
Change in Working Capital
Change in Accured Expenses 0.05M0.08M0.13M-0.03M-0.02M0.03M-0.01M0.09M0.17M-0.10M-0.13M0.30M-0.33M0.16M-0.02M
Other Working Capital Changes -0.01M-0.00M-0.00M0.14M0.03M0.05M0.04M-0.12M0.02M-0.01M-0.01M-0.01M0.04M-0.16M0.08M
Investing Activities
Acquisitions 1.00
Financing Activities
Cash from Financing Activities 0.99M1.04M7.50M0.01M-0.21M-0.01M-0.01M-0.01M9.39M0.51M0.95M6.73M
Additional items
Exchange Rate Effect -0.00M-813.00-11.00-0.00M821.00-0.01M0.00M-0.00M0.00M0.00M
Change in Cash 0.68M0.73M6.31M-0.81M-0.81M-0.75M-0.60M-0.73M-1.01M-0.75M-0.64M8.72M-0.62M-0.05M5.44M
Beginning Cash Balance 2.87M2.87M3.55M4.28M10.59M9.78M8.97M8.22M7.62M6.89M5.88M5.13M4.49M13.21M12.59M12.55M
Free Cash Flow -0.31M-0.31M-1.19M-0.82M-0.81M-0.75M-0.60M-0.52M-1.00M-0.74M-0.61M-0.67M-1.13M-1.00M-1.30M
Net Cash Flow 0.68M0.73M6.31M-0.81M-0.81M-0.75M-0.60M-0.73M-1.01M-0.75M-0.63M8.72M-0.62M-0.05M5.43M